Bioretec Oy (HEL:BRETEC)

Finland flag Finland · Delayed Price · Currency is EUR
0.5720
-0.0100 (-1.72%)
At close: Dec 19, 2025
-72.89%
Market Cap17.61M
Revenuen/a
Net Incomen/a
Shares Out30.79M
EPSn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume228,379
Average Volume110,981
Open0.5920
Previous Close0.5820
Day's Range0.5700 - 0.6180
52-Week Range0.5680 - 2.9500
Beta0.57
RSI25.58
Earnings DateFeb 13, 2026

About Bioretec Oy

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatmen... [Read more]

Sector Healthcare
Founded 1998
Country Finland
Stock Exchange Nasdaq Helsinki
Ticker Symbol BRETEC
Full Company Profile

News

Bioretec Board Approves Updated Strategy, Financial Targets For 2026-2028 Period

(RTTNews) - Bioretec (0TN.F, BRETEC.HE) said Board of Directors has approved the company's updated strategy for 2026-2028 and new financial targets for the strategy period. Bioretec's new financial ta...

4 days ago - Nasdaq

Bioretec Secures FDA Breakthrough Device Designation For RemeOs DrillPin

(RTTNews) - Bioretec Oy (0TN.F, BRETEC.HE) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its magnesium alloy technology-based, biodegradable RemeO...

5 days ago - Nasdaq

Bioretec Ltd's business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

Bioretec Ltd Company announcement 15 May 2025 at 8:00 a.m. TAMPERE, Finland , May 15, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January- March 2025 . The com...

7 months ago - Benzinga